Our family of companies was included on a History Channel show that focused on how innovation is driving the rapidly expanding cannabis industry.
Medical Marijuana, Inc. and several of our portfolio and investment companies were highlighted in a recent segment on the History Channel show Innovations with Ed Begley, Jr. The show typically looks at the most recent breakthroughs and developments from a wide range of industries. Medical Marijuana, Inc. and our family of companies were featured on the show dedicated to the cannabis industry. Watch the full segment below:
Dr. Stuart Titus, CEO of Medical Marijuana, Inc. was interviewed first in the segment, providing some background on the incredible growth of the cannabis industry and Medical Marijuana, Inc.’s unique place within it.
He also revealed the role the endocannabinoid system plays in the proper functioning of the body and the potential to supplement this system with phytocannabinoids like CBD from the hemp plant.
The segment also took a close look at Medical Marijuana, Inc.’s CBD pipeline, which grows our hemp in Europe and then ships its extracted oil to our formulators in California before shipping our finished products around the world.
A Company of Firsts®, our company was the first to bring commercial CBD products to market, and we have innovated many of the industry standards in safety and reliability that have now become commonplace.
The History Channel show also interviewed the CEOs of several of Medical Marijuana, Inc.’s portfolio companies, including Blake Schroeder from Kannaway, who revealed the newest directions our family of companies is headed.
The segment also looked at Medical Marijuana, Inc.’s pharmaceutical companies, AXIM® Biotechnologies and Kannalife™ Sciences, which are developing new cannabinoid-based treatments for a wide range of medical indications.
As the cannabis industry continues to grow all over the globe, Medical Marijuana, Inc will be well positioned to take advantage of our newest innovations and to open previously unavailable markets to the benefits of cannabinoids.